SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is currently trending due to escalating regulatory scrutiny, including a referral to the Department of Justice, over its mass-marketed, non-FDA-approved compounded GLP-1 weight-loss drugs. This has ignited a fierce community debate between those predicting further stock declines due to legal risks and others who believe the company is resilient, compliant with compounding laws, and strategically positioned against traditional pharmaceutical giants.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending amid heightened focus on cannabis culture, with its community advocating for legalization, sustainable practices, and real-world utility, often describing it as "Bitcoin but way higher." While proponents highlight its low market cap and long-term vision, others warn of it being a pump-and-dump.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis shares are seeing a sharp decline following a major strategic overhaul that includes significant charges for realigning EV plans and a dividend cancellation, leaving the community divided on whether this represents a timely reset for the automaker or a critical sign of ongoing challenges in a turbulent market.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ, a 2x inverse ETF of MicroStrategy (MSTR), is trending due to a sharp decline in its price, triggered by a substantial rally in MSTR and Bitcoin, sparking intense community debate over the volatility and risks of this leveraged product. Many are reacting to losses from betting against MSTR's ascent, while others anticipate future pullbacks to find new entry points, all against the backdrop of polarized views on MicroStrategy's Bitcoin strategy.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as the Supreme Court recently agreed to review its patent infringement case against Hikma, intensifying community focus on intellectual property rights, while positive preliminary financial results and ongoing buyout speculation further drive investor conversation.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is a trending topic following its Q4 earnings beat, which was tempered by weaker 2026 guidance, as investors weigh the potential of its new significant ADAS deal with a major US automaker and the strategic $900 million acquisition of Mentee Robotics, signaling a push into humanoid AI.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is a key player in the 'Physical AI revolution,' with its digital lidar sensors seeing increasing adoption across robotics, smart infrastructure, and defense, diversifying beyond traditional automotive applications. The community is actively discussing the company's strong financial health, including consistent revenue growth and zero debt, alongside anticipation for key hardware updates and potential benefits from recent market consolidation within the lidar sector.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as its new Crypto.com partnership expands prediction markets with player-specific sports contracts, exciting some in the community for growth potential while others debate its competitive impact against platforms like Kalshi and regulatory oversight, all ahead of the Super Bowl and earnings.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is actively discussed by the community following its recent earnings report, which, despite beating estimates, saw the stock dip due to concerns over a substantial acquisition and future guidance. Investors are debating if the sell-off is an overreaction, pointing to its expanding multibillion-dollar AI security partnership with Google Cloud and the essential nature of cybersecurity in an era of increasing AI-driven threats.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF ($SMCX) is trending as its underlying asset, Super Micro Computer ($SMCI), reports strong results and bullish guidance, fueling widespread community discussion of an impending short squeeze. Traders are actively accumulating shares, noting high short interest and significant cost-to-borrow, despite the inherent volatility and decay of the leveraged ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Albireo Pharma Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

ALBO
Albireo Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ALBO News

ALBOAlbireo Pharma Inc